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The aim of this study was to investigate microbial pathogens and their antibiotic susceptibility profile in 
infected diabetic foot ulcers in Iranian patients. This was a one-year cross sectional study on diabetic 
patients with infected diabetic foot ulcer at Shariati Teaching Hospital, Tehran, Iran. Grade of ulcer was 
determined by Wagner’s criteria. Specimens were obtained from the base of ulcer, deep part of the 
wound or aspiration and were tested with gram staining and antibacterial susceptibility was determined 
with both disk diffusion and E-Test methods. Total of 546 pathogens were isolated from 165 ulcers of 
149 patients. Gram positive aerobes including Enterococcal species and methicillin resistant 
Staphylococcus aureus (S. aureus) (21.4 and 19.4%, respectively) were identified as the most common 
pathogens followed by Gram negative isolates including Escherichia coli and Pseudomonas-
aeruginosa (12.6 and 5.4%, respectively). The majority of wounds were classified as Wagner grades 2 
and 3 (15.7 and 75.7%). Appropriate empiric treatment to cover both these Gram positive and Gram 
negative pathogens is crucially important.  
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INTRODUCTION 
 
Foot ulceration and infection in diabetic patients is one of 
the major causes of morbidity, hospitalization and foot 
amputation (Lipsky et al., 2004). This complication 
accounts for approximately 20% of hospital admissions in 
diabetic patients (Bild et al., 1989; Abdulrazak et al., 2005). 
 
 
 
*Corresponding author. E-mail: emrc@sina.tums.ac.ir. Tel: +98-
21-88220037.Fax:+98-21-88220052. 
Diabetic foot infection leads to approximately 50% of non 
traumatic lower limb amputations in the United States 
(Abdulrazak et al., 2005). 
Diabetic foot infections include cellulitis, abscess, 
necrotizing fasciitis, septic arthritis, tendonitis and 
osteomyelitis. According to the previous studies, aerobic 
Gram positive cocci including Staphylococcus aureus and 
beta-hemolytic Streptococci are the major pathogens in 
the acute skin and soft tissue infections. Enterococci, 
Enterobacteriaceae   and   Pseudomonas   are  important  
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pathogens in chronic ulcers (Bild et al., 1989; Gerding, 
1995; Urbancic and Gubina, 2000; Abdulrazaket al., 
2005). In a European study on 78 diabetic patients, S. 
aureus (42.3%), Enterobacteriaceae (12.5%), coagulase 
negative Staphylococcal species (10.6%) and 
Pseudomonas aeruginosa (10.6%) were the most 
frequent organism isolated from foot infections (Bild et al., 
1989).  
Shariati hospital is one of the major medical centers 
affiliated to Tehran University of Medical Sciences. One 
of the core divisions in this teaching hospital is 
Endocrinology and Metabolism Research Center. The 
diabetes clinic of this center takes care of a considerable 
number of diabetic patients including those with diabetic 
foot infections. Designing an appropriate protocol for 
empiric antibacterial treatment for diabetic foot infections 
involves a multidisciplinary team work including 
endocrinologists, infectious diseases specialists, medical 
microbiologists, clinical pharmacists and nurses. 
However, yet there is no comprehensive national protocol 
and guideline for empiric treatment of infected diabetic 
foot ulcer (considering microbial pathogens isolated in 
our patients) in Iran.  
This issue urged to investigate microbial pathogens 
responsible for diabetic foot infection. So, the aim of this 
study was to determine microbial and antimicrobial 
susceptibility profile of infected diabetic foot ulcer in 
Iranian patients. 
 
 
MATERIALS AND METHODS 
 
The total number of 149 diabetic patients with infected foot ulcer 
participated in this cross sectional study at Endocrinology and 
Metabolism Research Center, Shariati hospital, Tehran, Iran, from 
January 2008 to January 2009. All patients were admitted to 
outpatient diabetes clinic inside the hospital campus.  
Patients with clinical diagnosis of diabetic foot infection including 
superficial infected ulcers and osteomyelitis were included in the 
study. Patients who had received antibiotics (oral, topical, injection) 
within the previous week were excluded from the study. 
After explanation of the study details and aims, written informed 
consent was obtained. The study protocol was approved by the 
ethics committee of Endocrinology and Metabolism Research 
Center in accordance with Helsinki declaration and the guidelines of 
Iranian Ministry of Health and Medical Education.  
Wagner’s criteria were used for ulcer grading. The wound size, 
depth and its infection status were graded (Oyibo et al., 2001; 
Armstrong and Peters, 2001; Weigelt et al., 2009) also.  
Radiologic and imaging evaluation also were done by a simple 
foot X-ray and a triphasic bone scan (using 20 mCi Tc 99 m) of the 
whole body to rule out osteomyelitis. A venous blood sample was 
taken after overnight fasting for assessment of biochemical 
parameters. 
 
 
Microbiology and susceptibility testing 
 
After washing the wound with normal saline, the specimens were 
obtained from the base of the ulcer and deep part of the wound or 
by needle aspiration from the abscess. The specimens in 
thioglycollate tubes were sent  to  the  microbiology  laboratory  and  
 
 
 
 
incubated at 37°C for 24 h. After Gram staining, the  cultures on 
blood agar and MacConkey agar were incubated under aerobic and 
anaerobic conditions at 37°C for 48 h. 
Antibiotic susceptibility tests were done by both disk diffusion and 
Epsilometer test (E-test) methods on incubated isolates onto 
Mueller-Hinton agar plates (transferred from broth achieving 0.5 
McFarland visual turbidity standard) (Citron et al., 1991). E-test 
strips were obtained from AB BioMerieux Company, Solna, Sweden 
and the antibiotic disks were obtained from HiMedia Company, 
Mumbai. For this purpose, E-test strips and antibiotic disks were 
applied on separate plates and incubated for 24 h to evaluate the 
isolates’ susceptibility to antibiotics. The following antibiotic disks 
were used to assess susceptibility: ciprofloxacin 5 mcg/disk, 
penicillin 10 mcg/disk, ceftriaxone 30 mcg/disk, cephalotin 30 
mcg/disk, imipenem 10 mcg/disk, cefoxitin 30 mcg/disk, ceftizoxime 
30 mcg/disk, ticarcillin- clavulanate 75 to 10 mcg/disk, 
metronidozole 5 mcg/disk, meropenem 10 mcg/disk, gentamicin 10 
mcg/disk, amikacin 30 mcg/disk, clindamycin 2 mcg/disk, 
erythromycin 15 mcg/disk, ampicillin 10 mcg/disk, vancomycin 30 
mcg/disk, ceftazidime 30 mcg/disk. 
For E-test we used clindamycin 32 mcg, ceftazidime 256 mcg, 
vancomycin 256 mcg, meropenem 32 mcg strips. In the case 
bacterial occurred along the entire E-test strip, minimal inhibitory 
concentration (MIC) was reported as more than the highest value 
on the strip. If an E-test MIC value fell in-between two-fold dilutions, 
it was rounded up to the next upper value.  
Methicillin resistant Staphylococcus aureus (MRSA) was defined 
as S. aureus isolates resistant to cefoxitin by using disk diffusion 
susceptibility test. 
 
 
Statistical analyses 
 
Quantitative variables were expressed as means ± SD and 
qualitative variables were expressed as percentage. The 
association between independent variables with MRSA and 
methicillin sensitive Staphylococcus aureus (MSSA) was tested by 
using student's t-test and Chi square or Fisher's exact test as 
appropriate. Multiple logistic regression model with enter method 
was fitted to explore independent predictors of MRSA infections. 
The odds ratios (ORs) with 95% confidence interval (CI) were 
calculated for MRSA associated ulcers. A P-value less than 0.05 
was considered as statistically significant. Analyses were conducted 
by using STATA/SE 10.0 software. 
 
 
RESULTS 
 
Sixty percent of patients were male. Most of the patients 
were older than sixty years (45.7%). Eighty seven point 
nine percent of patients had type 2 diabetes. Duration of 
diabetes in 72.1% of the patients was equal or longer 
than 10 years and duration foot ulcers in 77.9% of 
patients was between one month and a year. Sixty two 
point nine percent of patient had poor diabetes control 
(HbA1C of 8% or higher). The majority of wounds were 
classified as Wagner grades 2 and 3 (15.7 and 75.7%, 
respectively). 
Total of 546 pathogens was isolated from 165 diabetic 
foot lesions of 149 patients with an average of 3.3 
pathogens per lesion. Gram positive aerobic agents 
including Enterococcus species and S. aureus (21.4 and 
19.4%, respectively) followed by Gram negative aerobic 
agents   including    Escherichia    coli    (E.    coli)      and  
Rouhipour et al.         5603 
 
 
 
Table 1. Frequency of each isolated bacteria from diabetic foot wounds (number of patients = 149). 
 
Bacterial category Frequency (%) 
n, isolates 546 
Aerobic and facultative isolates 536(98.1) 
Gram positive 338(61.9) 
Streptococcus-spp. 17(3.1) 
Group D Strep-Entrococcus 117(21.4) 
Group D Strep-Non Entrococcus 14(2.5) 
S. aureus 106(19.4) 
Staphylococcus epidermidis 68(12.4) 
Staphylococcus hemolyticus 14(2.5) 
Micrococcus-spp 2(0.3) 
Gram negative 198(36.2) 
E. coli 69(12.6) 
Citrobacter-spp 12(2.1) 
Kebsiella-spp 16(2.9) 
Pseudomonas-spp 4(0.7) 
Pseudomonas-aeroginoza 30(5.4) 
Klebsiella pneumoniae 15(2.7) 
Acinetobacter-spp 28(5.1) 
Citrobacter-freundai 6(1.01) 
Entrobacter-spp 10(1.6) 
Morganella-spp 7(1.1) 
Proteus Mirabillis 1(0.9) 
Anaerobic isolates 10(1.8) 
Pepto Streptoccocus 9(1.6) 
Bactereides Fragilis 1(0.1) 
 
 
 
Pseudomonas-aeruginosa (12.6 and 5.4%, respectively) 
were the most common pathogens in this population. 
Polymicrobial infection was seen in 89.4% whereas 
single pathogen etiology was seen in 9.3% of all cases. 
One point eight percent of all bacterial isolates were 
identified as anaerobes. Table 1 shows the frequency of 
all isolated bacteria from foot ulcers. 
Enterococcal species were the most common isolated 
bacteria from foot ulcers which majority of them (52.1%) 
were obtained from superficial wounds. Fifty three point 
one percent of MRSAs was isolated from superficial 
wounds versus 46.9% isolated from deep part of the 
wounds. 
Based on susceptibility test results (E-Test) 91.4% of 
Enterococcal species were susceptible to vancomycin. 
31.1% of S. aureus was MRSA which all of them were 
sensitive to vancomycin while 78.7% were resistant to 
clindamycin. About 94% of streptococcal isolates were 
susceptible to vancomycin. 
All P. aerogenosa isolates were resistant to ceftazidime 
while 10% of those isolates were resistant to 
meropenem. 43.1% of E. coli and none of Klebsiella 
species   were   resistant   to   ceftazidime  whereas  both 
organisms were susceptible to meropenem. As predicted, 
the rate of susceptibility to meropenem was higher than 
third generation cephalosporins (ceftazidime).  
Demographic characteristics and risk factors of 
participants and their relationship with frequency of 
MRSA and MSSA infections were shown in Table 2. 
Patients with duration of diabetes longer than 10 years 
had significantly higher risk for MRSA infections (OR = 
1.28, 1.06 to 1.60). Also there was a significant 
relationship between hyperlipidemia and the frequency of 
MRSA infections (OR = 4.05, 1.17 to 14). In Wagner 
grades 2 and 3 wounds the most common isolated 
bacteria was Enterococcus.  
The susceptibility of anaerobic bacteria were evaluated 
by both E-Test and disk diffusion methods. Tables 3 and 
4 show the results obtained from each of these two 
methods for both aerobic and anaerobic isolates. 
 
 
DISCUSSION 
 
In this study, a comprehensive evaluation of 
microbiological profile and  antimicrobial  susceptibility  of 
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Table 2. Relationship between risk factors with frequency of MRSA and MSSA infections. 
 
Characteristic MSSA n (%) N = 122 MRSA n (%) N = 16 P-value OR CI% 95 
Sex Female 41(33.6) 7(43.8) - 1 - Male 81(65.9) 9(56.3) 0.45 0.66 0.23 - 1.91 
      
Age(year) 59.23 ± 11.02 54.12 ± 9.50 0.08 0.95 0.91 - 1.00 
<50 26(21.3) 6(37.5) - 1 - 
50-59 37(30.3) 5(31.3) 0.41 0.58 0.16 - 2.12 
>=60 59(48.4) 5(31.3) 0.12 0.23 0.10 - 1.31 
      
Type of diabetes Type 1 16(13) 1(6.3) - 1 - Type 2 106(86.8) 15(93.8) 0.45 2.24 0.27-18.15 
      
Duration of diabetes 15.19 ± 8.81 16.50 ± 11.89 0.60 1.01 0.96-1.07 
<10 years 89(74.2) 11(68.8) - 1 - 
≥10 years 31(25.8) 5(31.1) 0.02* 1.28 1.06-1.60 
Duration of Ulcer (month) 5.44 ± 9.13 7.28 ± 8.52 0.46 1.01 0.97-1.06 
< 1month 13(10.8) 1(6.3) - 1 - 
1-11 months 97(80.8) 11(68.8) 0.72 1.47 0.17 - 12.37 
≥12 months 10(8.3) 4(25) 0.16 5.20 0.5 - 54.00 
      
Complications 
 
Hypertension 56(46.7) 8(50) 0.42 0.61 0.19 - 2.01 
Hyperlipidemia 48(40) 11(68.8) 0.02* 4.05 1.17 - 14.00 
Osteomyelitis 99(82.5) 14(87.5) 0.61 1.50 0.30 - 7.38 
Smoking 48(40) 11(68.8) 0.58 1.40 0.41 - 4.75 
      
HbA1C (%) 8.92 ± 1.92 8.52±1.75 0.42 0.88 0.66 - 1.19 
<7% 20(16.8) 3(18.8) - 1 - 
7-7.9% 22(18.5) 8(18.8) 0.91 0.90 0.16 - 5.03 
≥8% 77(64.7) 10(63.5) 0.83 0.86 0.31 - 3.44 
FBS(mg/dl) 179.72 ± 74.27 180.43 ± 68.68 0.97 1.00 0.99 - 1.007 
<126 30(25.2) 3(18.8) - 1 - 
126-175 31(26.1) 6(37.5) 0.38 1..93 0.44 - 8.45 
176-226 35(29.4) 3(18.8) 0.85 0.85 0.16 - 4.56 
>226 23(19.3) 4(25) 0.50 1.73 0.35 - 8.54 
      
Depth of ulcer(cm) 0.47 ± 0.90 0.71 ± 0.89 0.31 1.28 0.80 - 2.08 
≤0.5 77(64.7) 7(43.8) - 1 - 
Rouhipour et al.         5605 
 
 
 
Table 2. Cont. 
 
>0.5 42(35.3) 9(56.3) 0.19 2.52 0.61 - 10.3 
      
Size of ulcer(cm2) 8.53 ± 24.51 7.15 ± 7.01 0.82 0.99 0.96 - 1.02 
≤4 64(57.8) 7(43.8) - 1 - 
>4 55(46.2) 9(56.3) 0.45 1.49 0.52 - 4.28 
 
MRSA = Methiciline resistant s. aureus; MSSA = Methiciline sensitive s. aureus. *, Significant.  
 
 
 
Table 3. E-Test, susceptibility results of Gram positive, Gram negative and anaerobic isolates. 
 
E-Test Vancomycin n (%) Clindamycin n (%) Metronidazole 
Gram positive isolates 
   
MRSA 33 (100) 5 (15.1)  
MSSA 75 (98.6) 50 (65.7)  
S. Epidermidis 60 (88.2) 31 (45.5)  
Group D Strep-Entrococcus 107 (91.4)   
Streptococcus-spp 16 (94.1)   
Group D Strep-Non Entrococcus 12 (85.7)   
S. aureus 106 (99.5) 55 (51.8)  
S. hemolyticus 14 (100) 10 (71.4)  
Micrococcus-spp 2 (100) 2 (100)  
   
 
Gram negative isolates Merpenem Ceftazidim 
 
Pseudomonas-aeroginoza 27 (90) 30 (100)  
E. coli 69 (100) 28 (40)  
Entrobacter-spp 10 (100) 8 (80)  
Acinetobacter-spp 16 (57.1) 16 (57.1)  
Citrobacter-spp 12 (100) 8(66.6)  
Kebsiella-spp 14 (87.5) 14(87.5)  
Pseudomonas-spp 4 (100) 0  
Klebsiella pneumonia 15 (100) 13 (86.6)  
Citrobacter-freundai 6 (100) 4 (66.6)  
Morganella-spp 6 (85.7) 7 (100)  
Proteus mirabilis 1 (100) 1 (100)  
    
Anaerobic isolates Clindamycin Merpenem  
Pepto Streptoccoccoc 5 (55.5) 9 (100) 0 
Bactereides Fragilis 0 1 (100) 1 (100) 
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Table 4. Disk diffusion, susceptibility results (number and percentage) of Gram positive, Gram negative isolates and anaerobic isolates. 
 
Characteristic Citrobacter spp P. aeruginosa Klebsiella pneumoniae Klebsiella spp Enterobacter spp E. coli Acinetobacter spp 
Gram negative        
Ciprofloxacin  10 (83.3) 27 (90) 9 (60) 14 (87.5) 8 (80) 17(24.6) 18 (64.2) 
Ceftazidim 10(83.3) 29(96.6) 4(26.6) 14(87.5) 9(90) 24(34.7) 11(39.2) 
Merpenem 12(100) 29(96.6) 15(100) 14(87.5) 10(100) 66(95.6) 25(89.2) 
Imipenem 12(100) 30(100) 15(100) 14(87.5) 10(100) 69(100) 19(67.8) 
Amoxi/clave 2(18.1) 0 0 1(6.2) 0 3(4.3) 2(7.1) 
Ceftriaxone 10(83.3) 0 12(80) 10(62.5) 10(100) 21(30.4) 6(21.4) 
Ceftizoxim 10(83.3) 1(3.3) 14(93.3) 14(87.5) 10(100) 38(55) 14(50) 
Gram positive S. aureus S. epidermidis Streptococcus spp Enterococcus spp    
Vancomycin 106(100) 68(100) 17(100)) 62(64.9)    
Cefoxitin 73(68.8) 48(70.5)      
Ciprofloxacin  59(55.6) 37(54.4)      
Merpenem 100(94.3) 60(88.2)      
Clindamycin 35 (33) 27 (35.2) 11(64.7) 0    
Amoxi/clave 28 (26.4) 33 (48.5)      
Ampicillin   15(88.2) 113(96.5)    
Ceftraxone   8(47) 5(4.2)    
Amikacin   1(5.8) 4(3.4)    
Ciprofloxacin    8(48) 54(46.1)    
Penicillin   14(82.3) 32(27.3)    
Gentamicin   6(35.2) 50(42.7)    
Anaerobic isolates Pepto Streptococci Bactereides Fragilis      
Vannomycin 9(100) 0      
Cefalotin 9(100) 1(100)      
Ceftizoxim 9(100) 0      
Merpenem 9(100) 0      
Clindamycin 5(55.5) 0      
Imipenem 9(100) 0      
Ampicillin 9(100) 0      
Ceftriaxone 4(44.4) 0      
Amikacin 2(22.2) 1(100)      
Cotimoxazole 7(77.7) 0      
Penicillin 9(100) 0      
Gentamicin 0 1(100)      
Erythromaycin 7(77.7) 0      
Metronidazole 2(22.2) 0      
  
 
 
infected diabetic foot ulcer in diabetic patients referred to 
diabetic   clinic   was done.  Univariate analysis showed 
significant association of hyperlipidemia, duration of 
diabetes and age (years) with prevalence of MRSA 
whereas duration of diabetes and hyperlipidemia were 
the only independent risk factors of MRSA infections in 
multivariate analysis. This is while according to the 
results, duration of diabetic ulcer, type of diabetes and 
HbA1C level did not have significant effect on the 
prevalence of MRSA infections.  
In an Indian study on 80 patients with Wagner’s grades 
3 to 5 diabetic foot ulcers, aerobic Gram negative 
organisms (51.4%) and aerobic Gram positive organisms 
(33.3%) were the most common isolated pathogens. In 
that study, over 70% of the patients were positive for 
multidrug resistant organisms including extended 
spectrum beta-lactamase (ESBL) positive bacteria and 
MRSA (Gadepalli et al., 2006).  
In a recent study on 440 diabetic patients with diabetic 
foot infection in Kuwait, 777 pathogens were isolated. In 
that study, the most common pathogens isolated from the 
lesions were aerobic Gram-negative bacteria (51.2%), 
Gram-positives (32.3%) and anaerobes (15.3%), 
respectively.  
The finding of this study is something different from 
ours. In our study in contrast to Kuwait study, Gram 
positive bacteria were the most common isolated 
pathogens whereas in that study Gram negatives were 
the most common isolates. The most common Gram 
negative organism in Kuwait study was P. aeruginosa 
while it was the second common organism in our study. 
In that study, S. aureus was detected as the most 
common Gram positive bacteria whereas in our study it 
was the second most common pathogen and E. coli was 
the first. Polymicrobial infection in that study (75%) was 
less than our study (89.4%). This comparison shows that 
although both countries (Iran and Kuwait) are in the same 
region but the microbial pattern of diabetic foot infection 
is different. 
In a study conducted by Raja (2007) in Malaysia on 
194 patients, 287 pathogens were isolated that like 
Kuwait study Gram Negative bacteria (Proteus species 
and P. aeruginosa) were predominant which is different 
from our findings. The most frequent detected organisms 
in that study are different from ours (Raja, 2007). 
Average number of pathogens per lesion in our study 
(3.3) was more than Kuwait, Malaysia and even United 
State studies (1.8, 1.47 and 2.7%, respectively) (Citron et 
al., 2007; Raja, 2007; Benwan et al., 2012).  
An Iranian prospective study on 32 diabetic patients in 
2006, revealed polymicrobial etiology in 50% of the 
patients. Aerobic Gram negative rods (54.8%) and gram 
positive cocci (42.9%) were frequent isolates. All cultured 
microorganisms showed high resistance to the antibiotic 
treatments used in the study. The highest resistance 
against antibacterial agents was seen in S. aureus and P. 
aeruginosa (Alavi et al., 2007).  
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A number of other previous studies concluded that Gram 
positive aerobes were responsible for the majority of 
diabetic foot ulcer infections in their patients (Mantey et 
al., 2000; Fejfarova et al., 2002). Although in the present 
study Enterococcal species were the most common 
pathogens isolated from diabetic foot ulcer, other studies 
like Joseph et al. study, showed group B Streptococci as 
the predominant cause of diabetic foot infections 
(Joseph, 1991). In this study, as it was predicted, the 
Gram negative isolates including Pseudomonas and 
Klebsiella species showed higher resistance to third 
generation cephalosporins than carbapenems and this 
could be due to the large number of prescriptions of 
cephalosporins over a long period of the time for diabetic 
patients with foot ulcers. Antimicrobial susceptibility in our 
study was somewhat similar to Raja (2007) study. 
The difference in findings in different studies (Citron et 
al., 2007; Raja, 2007; Benwan et al., 2012) may be due 
to the difference in sample size, specimen collection 
method, site of specimen collection, microbial detection 
method, antimicrobial agent used and geographical 
region and culture.  
 
 
Conclusion 
 
In conclusion, according to the results, Enterococci and 
Staphylococci were the most common pathogens in the 
infected diabetic foot ulcers followed by Gram negative 
aerobes like E. coli and Klebsiella species. The difference 
in microbial pattern of diabetic foot infection in various 
studies shows that the empirical therapy in each country 
should be selected considering the most common 
specific pathogen of the region and its antimicrobial 
susceptibility. Since this study was performed on 
outpatients and based on the susceptibility results, it 
seems it is crucially important to start such an empiric 
antibacterial treatment to cover both Gram positive 
(including MRSA) and Gram negative bacteria. 
Antimicrobial susceptibility results showed that 
vancomycin and merpenem may be appropriate agents 
for empirical therapy in Iran. 
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